Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

SHA:603229 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,159	8,295	7,834	9,564	10,451	8,765
Market Cap Growth	9.30%	5.87%	-18.09%	-8.49%	19.25%	170.38%
Enterprise Value	7,400	7,572	7,115	9,183	9,848	8,455
Last Close Price	9.85	9.88	9.22	11.80	12.88	10.78
PE Ratio	44.49	40.11	30.86	40.64	71.62	100.93
Forward PE	37.17	25.95	22.58	34.87	54.34	11.21
PS Ratio	10.86	10.43	9.59	12.51	18.35	21.42
PB Ratio	3.48	3.65	3.66	6.55	8.33	7.78
P/TBV Ratio	3.72	3.92	3.94	7.36	9.58	8.35
P/FCF Ratio	56.74	124.50	134.20	-	-	192.56
P/OCF Ratio	33.76	46.62	35.32	79.33	60.10	63.30
EV/Sales Ratio	9.85	9.52	8.71	12.01	17.29	20.66
EV/EBITDA Ratio	33.43	30.50	24.96	38.32	54.04	62.95
EV/EBIT Ratio	52.34	40.78	29.10	44.75	64.70	77.65
EV/FCF Ratio	51.46	113.66	121.89	-	-	185.75
Debt / Equity Ratio	0.16	0.12	0.14	0.17	0.09	0.04
Debt / EBITDA Ratio	1.70	1.09	1.06	1.01	0.60	0.31
Debt / FCF Ratio	2.62	4.09	5.19	-	-	0.90
Asset Turnover	0.25	0.27	0.31	0.37	0.35	0.36
Inventory Turnover	0.92	0.98	1.09	1.32	1.21	0.97
Quick Ratio	2.13	1.92	1.63	1.01	1.40	3.22
Current Ratio	2.84	2.53	2.17	1.53	1.92	4.02
Return on Equity (ROE)	7.96%	9.37%	14.09%	17.33%	12.25%	9.80%
Return on Assets (ROA)	2.91%	3.91%	5.80%	6.17%	5.91%	6.00%
Return on Invested Capital (ROIC)	7.71%	11.56%	17.71%	21.20%	24.91%	25.49%
Return on Capital Employed (ROCE)	5.80%	8.00%	11.20%	13.10%	11.60%	9.60%
Earnings Yield	2.27%	2.49%	3.24%	2.46%	1.40%	0.99%
FCF Yield	1.76%	0.80%	0.74%	-1.58%	-1.31%	0.52%
Dividend Yield	1.01%	1.01%	1.00%	0.48%	0.29%	0.21%
Payout Ratio	48.89%	40.73%	22.63%	16.00%	13.69%	15.43%
Buyback Yield / Dilution	-3.53%	-0.99%	-1.92%	-1.16%	-6.67%	-0.25%
Total Shareholder Return	-2.51%	0.02%	-0.92%	-0.68%	-6.38%	-0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.